Short Interest in Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHF) Declines By 42.3%

Kissei Pharmaceutical Co., Ltd. (OTCMKTS:KSPHFGet Free Report) was the recipient of a large decline in short interest in August. As of August 31st, there was short interest totalling 11,300 shares, a decline of 42.3% from the August 15th total of 19,600 shares. Based on an average daily volume of 0 shares, the short-interest ratio is presently ∞ days.

Kissei Pharmaceutical Stock Performance

Shares of Kissei Pharmaceutical stock opened at $18.81 on Friday. Kissei Pharmaceutical has a twelve month low of $17.71 and a twelve month high of $19.90. The business has a 50-day moving average price of $18.81 and a 200 day moving average price of $18.81.

About Kissei Pharmaceutical

(Get Free Report)

Kissei Pharmaceutical Co, Ltd. researches, develops, manufactures, and sells pharmaceutical products primarily in Japan. The company offers Kalogra tablets, for the treatment of ulcerative colitis; Tabuneos capsules for the treatment of microscopic polyangiitis and granulomatous polyangiitis; Minirin Melt OD tablets; Malizeb tablets; Tavaris tablets for the treatment of chronic idiopathic thrombocytopenic purpura; Beova tablets for the treatment of overactive bladder treatment; and Darbepoetin Alfa BS injection JCR for the treatment of renal anemia.

Featured Articles

Receive News & Ratings for Kissei Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kissei Pharmaceutical and related companies with's FREE daily email newsletter.